NTRA
NTRA
NASDAQ · Biotechnology

Natera Inc

$322.10
+56.72 (+21.37%)
As of Aug 8, 9:37 PM ET ·
Analyst Consensus
Strong Buy
30
Analysts
Very High
Coverage
Buy 26 87%
Hold 4 13%
Sell 0 0%
Price Target
Analyst Price Target -55.6% upside
Low Target $88.14
Average Target $142.91
High Target $188.78
Current Price $322.10
Current
$322.10
Target
$142.91
$88.14 $142.91 avg $188.78
Scenario Analysis
Bear Case
$88.14
-72.6%
Low target
Base Case
$142.91
-55.6%
Avg target
Bull Case
$188.78
+-41.4%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$288.04
11.8% from high
52-Week Low
$135.75
+137.3% from low
50-Day SMA
$229.31
+40.5% vs SMA
200-Day SMA
$186.42
+72.8% vs SMA
RSI (14)
38.6
Neutral
Target vs 52W High
$142.91
-50.4% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +4.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -53.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +172.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -11.6%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -55.6%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.4%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.0%